Health Condition 1: L814- Other melanin hyperpigmentation
Conditions
Interventions
Intervention1: Topical Unani Formulation: Dosage form-: Qurs (tablet) for topical application
Mode of Administration: Qurs will be crushed and Zimad (paste) for topical application will be prepared by
Sponsors
National Research Institute of Unani Medicine for Skin Disorders
Eligibility
Inclusion criteria
Inclusion criteria: The following patients will be included in the study Participants of any gender in the age group of 18-60 years Participants having bilateral symmetrical or asymmetrical brown macules on face Participants who are willing to participate and comply with the protocol and to sign IEC approved ICF
Exclusion criteria
Exclusion criteria: Exclusion Criteria The following patients will be excluded from the study Participants aged less than 18 years and more than 60 years of age Pregnant or Lactating Women Mentally retarded person Known allergy, sensitivity or intolerance to the study drug or any of its ingredients Known case of significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction, Malignancy, HIV infection, AIDS, Hypothyroidism, Diabetes Mellitus, etc Participants not willing to give consent and to attend treatment schedule regularly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in MASI Score from baseline after 4 weeks of treatment.Timepoint: 28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Melasma Quality of Life (MELASQoL) Scale Score from baseline after 4 weeks of treatment. Assessment of Safety (Local & Systemic) Timepoint: 28 days | — |
Countries
India
Contacts
Public ContactProf Qamar Uddin
National Research Institute of Unani Medicine for Skin Disorders
Outcome results
None listed